Cargando…
Relating genomic variation to drug response in childhood acute lymphoblastic leukemia by multiplexed targeted sequencing
Autores principales: | Wesolowska, Agata, Dalgaard, Marlene D, Borst, Louise, Gautier, Laurent, Bak, Mads, Weinhold, Nils, Nielsen, Betina F, Nersting, Jacob, Tommerup, Niels, Brunak, Søren, Ponten, Thomas Sicheritz, Leffers, Henrik, Schmiegelow, Kjeld, Gupta, Ramneek |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026272/ http://dx.doi.org/10.1186/gb-2010-11-s1-p41 |
Ejemplares similares
-
Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia
por: Nersting, Jacob, et al.
Publicado: (2011) -
Genome-Wide Assessment of the Association of Rare and Common Copy Number Variations to Testicular Germ Cell Cancer
por: Edsgärd, Daniel, et al.
Publicado: (2013) -
Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients
por: Wesołowska-Andersen, A, et al.
Publicado: (2015) -
Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
por: Schmiegelow, Kjeld, et al.
Publicado: (2014) -
Choice of bacterial DNA extraction method from fecal material influences community structure as evaluated by metagenomic analysis
por: Wesolowska-Andersen, Agata, et al.
Publicado: (2014)